These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11166877)
41. Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance. Xie E; Kotha A; Biaco T; Sedani N; Zou J; Stashenko P; Duncan MJ; Campos-Neto A; Cayabyab MJ PLoS One; 2015; 10(11):e0143422. PubMed ID: 26618634 [TBL] [Abstract][Full Text] [Related]
42. Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy. Starks H; Bruhn KW; Shen H; Barry RA; Dubensky TW; Brockstedt D; Hinrichs DJ; Higgins DE; Miller JF; Giedlin M; Bouwer HG J Immunol; 2004 Jul; 173(1):420-7. PubMed ID: 15210801 [TBL] [Abstract][Full Text] [Related]
43. Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route. Oh SH; Kim SH; Jeon JH; Kim EB; Lee NK; Beck S; Choi YJ; Kang SK Vaccine; 2021 Jul; 39(30):4072-4081. PubMed ID: 34127296 [TBL] [Abstract][Full Text] [Related]
44. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. Stevenson A; Roberts M FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115 [TBL] [Abstract][Full Text] [Related]
45. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Scheppler L; Vogel M; Zuercher AW; Zuercher M; Germond JE; Miescher SM; Stadler BM Vaccine; 2002 Jul; 20(23-24):2913-20. PubMed ID: 12126902 [TBL] [Abstract][Full Text] [Related]
46. New use of BCG for recombinant vaccines. Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554 [TBL] [Abstract][Full Text] [Related]
47. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Aldovini A; Young RA Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750 [TBL] [Abstract][Full Text] [Related]
48. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726 [TBL] [Abstract][Full Text] [Related]
49. Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus. O'Flaherty S; Klaenhammer TR Appl Environ Microbiol; 2016 Oct; 82(20):6091-6101. PubMed ID: 27496774 [TBL] [Abstract][Full Text] [Related]
50. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. Liao J; Gibson JA; Pickering BS; Watnick PI mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145 [TBL] [Abstract][Full Text] [Related]
53. Oral vaccination using recombinant bacteria. Schödel F Semin Immunol; 1990 Sep; 2(5):341-9. PubMed ID: 2134017 [TBL] [Abstract][Full Text] [Related]
54. Induction of protective immunity against microbial challenge by targeting antigens expressed by probiotic bacteria to mucosal dendritic cells. Mohamadzadeh M Curr HIV Res; 2010 Jun; 8(4):323-9. PubMed ID: 20353394 [TBL] [Abstract][Full Text] [Related]
55. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization. Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577 [TBL] [Abstract][Full Text] [Related]